Federal rules and regulations related to transparency of prescription drug studies and prohibitions on off-label marketing are the focus of papers in the December 2011 issue of Health Affairs. In addition, a separate study examines the effect of prior
Read More...
Read the complete post at http://healthaffairs.org/blog/2011/12/08/december-ha-issue-features-rx-drug-studies/
Posted
Dec 08 2011, 01:17 PM
by
Health Affairs Blog